Journal of Medicinal Chemistry p. 4913 - 4946 (2021)
Update date:2022-07-30
Topics:
Rohde, Jason M.
Karavadhi, Surendra
Pragani, Rajan
Liu, Li
Fang, Yuhong
Zhang, Weihe
McIver, Andrew
Zheng, Hongchao
Liu, Qingyang
Davis, Mindy I.
Urban, Daniel J.
Lee, Tobie D.
Cheff, Dorian M.
Hollingshead, Melinda
Henderson, Mark J.
Martinez, Natalia J.
Brimacombe, Kyle R.
Yasgar, Adam
Zhao, Wei
Klumpp-Thomas, Carleen
Michael, Sam
Covey, Joseph
Moore, William J.
Stott, Gordon M.
Li, Zhuyin
Simeonov, Anton
Jadhav, Ajit
Frye, Stephen
Hall, Matthew D.
Shen, Min
Wang, Xiaodong
Patnaik, Samarjit
Boxer, Matthew B.
Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are oncogenic for a number of malignancies, primarily low-grade gliomas and acute myeloid leukemia. We report a medicinal chemistry campaign around a 7,7-dimethyl-7,8-dihydro-2H-1λ2-quinoline-2,5(6H)-dione screening hit against the R132H and R132C mutant forms of isocitrate dehydrogenase (IDH1). Systematic SAR efforts produced a series of potent pyrid-2-one mIDH1 inhibitors, including the atropisomer (+)-119 (NCATS-SM5637, NSC 791985). In an engineered mIDH1-U87-xenograft mouse model, after a single oral dose of 30 mg/kg, 16 h post dose, between 16 and 48 h, (+)-119 showed higher tumoral concentrations that corresponded to lower 2-HG concentrations, when compared with the approved drug AG-120 (ivosidenib).
View MoreHangzhou jls Flame Retardants Chemical Co.,Ltd
Contact:+86-571-87250387/87250386
Address:MOGANSHAN RODA 1418# SHANGCHENG INDUSTRIAL PARK
Contact:13120882795;+86-21-34621078;+86-021-31122318
Address:Suite 2,No.2715 Longwu Road
Shao Xing Empire Import&Export CO.,ltd
Contact:86-575-82127757
Address:11#, Weiwu Road, Shangyu Industrial Park, Hangzhou Bay, Hangzhou, Zhejiang Province, China
KA-SHING Business Trade Macau Co., Ltd.
Contact:00853-28430045
Address:23rd Floor, Block 3 La Cite, Areia Preta, Macao
website:http://www.shochem.com
Contact:021-50800795
Address:No.1043, Halei Rd, Zhangjiang Hi-Tech Park, Shanghai, Postcode 201203, China
Doi:10.1016/0022-328X(88)80340-1
(1988)Doi:10.1039/b905940g
(2009)Doi:10.1016/j.bmcl.2016.12.076
(2017)Doi:10.1016/j.bmc.2009.04.034
(2009)Doi:10.1021/jo00262a019
(1989)Doi:10.1016/S0040-4039(00)82060-2
(1988)